ArticleJournal of neurosurgery. Case lessons2025
Rare osseous mastoid invasion of secondary gliosarcoma: illustrative case.
Article in Journal of neurosurgery. Case lessons, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGliosarcomas are rare isocitratedehydrogenase-wildtype glioblastomas characterized by their glial and sacromatous components. A gliosarcoma is primary if the tumor arose de novo and secondary if the tumor arose from a previous glioblastoma. Here, the authors describe a unique case of a secondary gliosarcoma invading the mastoid and affecting the horizontal segment of the facial nerve. OBSERVATIONS: A 69-year-old female presented to the emergency department with 2 weeks of right-sided facial weakness. Six years earlier, she had undergone a gross-total resection for a right temporal glioma and was treated with chemoradiotherapy postoperatively. Pathology confirmed isocitrate dehydrogenase-negative, O6-methylguanine-DNAmethyltransferase-methylated glioblastoma. At current presentation, MRI demonstrated a right temporal tumor that invaded the mastoid. After surgical debulking, the tumor was confirmed to be a secondary gliosarcoma. CT of the temporal bone showed significant tegmen destruction and direct invasion of the horizontal segment of the facial nerve. LESSONS: Facial weakness was a symptom of the secondary glioscarcoma tumor invading the mastoid and affecting the horizontal segment of the facial nerve. To the authors' knowledge, this symptom has not been previously reported and thus adds to the limited knowledge of secondary gliosarcoma presentations. https://thejns.org/doi/10.3171/CASE25179.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.